Stay updated with breaking news from Teva Pharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A fractured affirmance of a district court decision to dismiss an infringement action under 35 U.S.C. § 271(e)(1) was the occasion for the Federal Circuit to illustrate the continued...
The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's May 2023 ruling in Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), a highly anticipated decision...
The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's May 2023 ruling in Amgen Inc. v. Sanofi, 598 U.S. 594 , a highly anticipated decision concerning...
The U.S. Court of Appeals for the First Circuit may soon contribute to a widening circuit split over the issue of what causation standard under the Anti-Kickback Statute (AKS) triggers liability...
The USPTO has made precedential a recent PTAB decision, Penumbra, Inc. v. RapidPulse, Inc., where the PTAB reaffirmed the USPTO's existing position that Dynamic Drinkware does not apply to AIA patents.